Merck & Co., Inc. has closed an underwritten public offering of multiple series of notes, raising significant capital through various debt instruments. The offerings include $500 million of Floating Rate Notes due 2029, $750 million of 3.850% Notes due 2029, $1 billion of 4.150% Notes due 2031, $1 billion of 4.450% Notes due 2032, $1.5 billion of 4.750% Notes due 2035, $750 million of 5.500% Notes due 2046, $1.5 billion of 5.550% Notes due 2055, and $1 billion of 5.700% Notes due 2065. These notes were issued under the company's shelf registration statement filed with the SEC. The offering closed on December 4, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-055388), on December 04, 2025, and is solely responsible for the information contained therein.